Engineering of a genome-reduced host: practical
application of synthetic biology in the overproduction of desired
secondary metabolites
Engineering of a genome-reduced host: practical
application of synthetic biology in the overproduction of desired
secondary metabolites
Hong Gao1,Elizabeth Ashforth1,Lixin Zhang1,Ying Zhuo2,
1.CAS Key Laboratory of
Pathogenic Microbiology & Immunology, Institute of Microbiology,
Chinese Academy of Sciences (CAS), Beijing 100101, China.; 2.CAS Key Laboratory of
Pathogenic Microbiology & Immunology, Institute of Microbiology,
Chinese Academy of Sciences (CAS), Beijing 100101, China.；Graduate University
of Chinese Academy of Sciences, Beijing 100049, China.;
Abstract：Synthetic biology aims to design and build new biological systems with desirable properties, providing the foundation for the biosynthesis of secondary metabolites. The most prominent representation of synthetic biology has been used in microbial engineering by recombinant DNA technology. However, there are advantages of using a deleted host, and therefore an increasing number of biotechnology studies follow similar strategies to dissect cellular networks and construct genome-reduced microbes. This review will give an overview of the strategies used for constructing and engineering reduced-genome factories by synthetic biology to improve production of secondary metabolites.
. Engineering of a genome-reduced host: practical
application of synthetic biology in the overproduction of desired
secondary metabolites[J]. Protein Cell, 2010, 1(7): 621-626.
Hong Gao, Elizabeth Ashforth, Lixin Zhang, Ying Zhuo, . Engineering of a genome-reduced host: practical
application of synthetic biology in the overproduction of desired
secondary metabolites. Protein Cell, 2010, 1(7): 621-626.
Agapakis, C.M., and Silver, P.A. (2009). Synthetic biology: exploring and exploiting geneticmodularity through the design of novel biological networks. Mol Biosyst 5, 704–713. doi: 10.1039/b901484e
Aho, A.C., Donner, K., Hydén, C., Larsen, L.O., and Reuter, T. (1988). Low retinal noise in animals with low body temperatureallows high visual sensitivity. Nature 334, 348–350. doi: 10.1038/334348a0
Anné, J., and Van Mellaert, L. (1993). Streptomyces lividans as host for heterologous protein production. FEMS Microbiol Lett 114, 121–128. doi: 10.1111/j.1574-6968.1993.tb06561.x
Brawner, M., Poste, G., Rosenberg, M., and Westpheling, J. (1991). Streptomyces: a host for heterologous geneexpression. Curr Opin Biotechnol 2, 674–681. doi: 10.1016/0958-1669(91)90033-2
Cello, J., Paul, A.V., and Wimmer, E. (2002). Chemical synthesis of poliovirus cDNA: generation of infectious virus in theabsence of natural template. Science 297, 1016–1018. doi: 10.1126/science.1072266
Chakiath, C.S., and Esposito, D. (2007). Improved recombinational stability of lentiviral expressionvectors using reduced-genome Escherichia coli. Biotechniques 43, 466, 468, 470. doi: 10.2144/000112585
Chen, Y., Smanski, M.J., and Shen, B. (2010). Improvement of secondary metabolite production in Streptomyces by manipulating pathway regulation. Appl Microbiol Biotechnol 86, 19–25. doi: 10.1007/s00253-009-2428-3
Fujio, T. (2007). Minimum genome factory: innovationin bioprocesses through genome science. Biotechnol Appl Biochem 46, 145–146. doi: 10.1042/BA20060117
Gao, H., Zhou, X., Gou, Z., Zhuo, Y., Fu, C., Liu, M., Song, F., Ashforth, E., and Zhang, L. (2010). Rational design for over-production of desirable microbial metabolites by precision engineering. Antonie van Leeuwenhoek. In press. doi: 10.1007/s10482-010-9442-4
Gil, R., Silva, F.J., Peretó, J., and Moya, A. (2004). Determination of the core of a minimal bacterial gene set. Microbiol Mol Biol Rev 68, 518–537. doi: 10.1128/MMBR.68.3.518-537.2004
Harada, K. (2004). Production of secondary metabolitesby freshwater cyanobacteria. Chem Pharm Bull (Tokyo) 52, 889–899. doi: 10.1248/cpb.52.889
Horsman, G.P., Van Lanen, S.G., and Shen, B. (2009). Iterative type I polyketide synthases for enediyne core biosynthesis. Methods Enzymol 459, 97–112. doi: 10.1016/S0076-6879(09)04605-9
Huang, K.X., Xia, L., Zhang, Y., Ding, X., and Zahn, J.A. (2009). Recent advances in the biochemistry of spinosyns. Appl Microbiol Biotechnol 82, 13–23. doi: 10.1007/s00253-008-1784-8
Jin, Z.H., Xu, B., Lin, S.Z., Jin, Q.C., and Cen, P.L. (2009). Enhanced production of spinosad in Saccharopolyspora spinosa by genome shuffling. Appl Biochem Biotechnol 159, 655–663. doi: 10.1007/s12010-008-8500-0
Komatsu, M., Uchiyama, T., Omura, S., Cane, D.E., and Ikeda, H. (2010). Genome-minimized Streptomyces host for the heterologous expression of secondary metabolism. Proc Natl Acad Sci U S A 107, 2646–2651. doi: 10.1073/pnas.0914833107
Koonin, E.V. (2003). Comparative genomics, minimal gene-setsand the last universal common ancestor. Nat Rev Microbiol 1, 127–136. doi: 10.1038/nrmicro751
Kwok, R. (2010). Five hard truths for synthetic biology. Nature 463, 288–290. doi: 10.1038/463288a
Lee, J.H., Sung, B.H., Kim, M.S., Blattner, F.R., Yoon, B.H., Kim, J.H., and Kim, S.C. (2009). Metabolic engineering of a reduced-genome strain of Escherichia coli for L-threonine production. Microb Cell Fact 8, 2. doi: 10.1186/1475-2859-8-2
Liu, W., Christenson, S.D., Standage, S., and Shen, B. (2002). Biosynthesis of the enediyne antitumor antibiotic C-1027. Science 297, 1170–1173. doi: 10.1126/science.1072110
Matsushima, P., and Baltz, R. (1994). Transformation of Saccharopolysoporaspinosa protoplasts with plasmid DNA modified in vitroto avoid host restriction. Microbiology 140, 139–143. doi: 10.1099/13500872-140-1-139
Matsushima, P., Broughton, M.C., Turner, J.R., and Baltz, R.H. (1994). Conjugal transfer of cosmid DNA from Escherichia coli to Saccharopolyspora spinosa: effects of chromosomal insertions on macrolideA83543 production. Gene 146, 39–45.
Mizoguchi, H., Mori, H., and Fujio, T. (2007). Escherichia coli minimum genome factory. Biotechnol Appl Biochem 46, 157–167. doi: 10.1042/BA20060107
Mizoguchi, H., Sawano, Y., Kato, J., and Mori, H. (2008). Superpositioning of deletions promotes growth of Escherichia coli with a reduced genome. DNA Res 15, 277–284. doi: 10.1093/dnares/dsn019
Morimoto, T., Kadoya, R., Endo, K., Tohata, M., Sawada, K., Liu, S., Ozawa, T., Kodama, T., Kakeshita, H., Kageyama, Y., et al. (2008). Enhanced recombinant protein productivity by genome reduction in Bacillus subtilis. DNA Res 15, 73–81. doi: 10.1093/dnares/dsn002
Murakami, K., Tao, E., Ito, Y., Sugiyama, M., Kaneko, Y., Harashima, S., Sumiya, T., Nakamura, A., and Nishizawa, M. (2007). Large scale deletions in the Saccharomyces cerevisiae genome create strainswith altered regulation of carbon metabolism. Appl Microbiol Biotechnol 75, 589–597. doi: 10.1007/s00253-007-0859-2
Ohnishi, Y., Ishikawa, J., Hara, H., Suzuki, H., Ikenoya, M., Ikeda, H., Yamashita, A., Hattori, M., and Horinouchi, S. (2008). Genome sequence of the streptomycin-producing microorganism Streptomyces griseus IFO 13350. J Bacteriol 190, 4050–4060. doi: 10.1128/JB.00204-08
Pósfai, G., Plunkett, G. 3rd, Fehér, T., Frisch, D., Keil, G.M., Umenhoffer, K., Kolisnychenko, V., Stahl, B., Sharma, S.S., de Arruda, M., et al. (2006). Emergent properties of reduced-genome Escherichia coli. Science 312, 1044–1046. doi: 10.1126/science.1126439
Reichenbach, H. (2001). Myxobacteria, producers of novelbioactive substances. J Ind Microbiol Biotechnol 27, 149–156. doi: 10.1038/sj.jim.7000025
Rokem, J.S., Lantz, A.E., and Nielsen, J. (2007). Systems biology of antibiotic production by microorganisms. Nat Prod Rep 24,1262–1287. doi: 10.1039/b617765b
Sharma, S.S., Blattner, F.R., and Harcum, S.W. (2007). Recombinant protein production in an Escherichia coli reduced genome strain. Metab Eng 9, 133–141. doi: 10.1016/j.ymben.2006.10.002
Tian, J., Gong, H., Sheng, N., Zhou, X., Gulari, E., Gao, X., and Church, G. (2004). Accurate multiplex gene synthesis from programmableDNA microchips. Nature 432, 1050–1054. doi: 10.1038/nature03151
Wang, L., Hu, Y., Zhang, Y., Wang, S., Cui, Z., Bao, Y., Jiang, W., and Hong, B. (2009). Role of sgcR3 in positive regulation of enediyne antibiotic C-1027 productionof Streptomyces globisporus C-1027. BMC Microbiol 9, 14. doi: 10.1186/1471-2180-9-14
Zhuo, Y., Zhang, W., Chen, D., Gao, H., Tao, J., Liu, M., Gou, Z., Zhou, X., BC, Y., Zhang, Q., et al. (2010). Reverse biological engineering of hrdB toenhance the production of avermectins in an industrial strain of Streptomyces avermitilis. Proc Natl Acad Sci U S A. In press.
